Net Loss Per Share (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2025

May 31, 2025

Dec. 31, 2024

Net Loss Per Share (Tables) [Line Items]

Schedule of Basic and Diluted Loss Per Share

The following table sets forth the computation of basic and diluted loss per share:

		For the six months ended June 30,
		2025				2024
		(Unaudited)				(Unaudited)
Numerator:
Net loss attributable to Aptorum Group Limited		$	(441,780	)		$	(2,643,796	)
Denominator:
Basic and diluted weighted average shares outstanding			7,126,796				5,339,608

Basic and diluted loss per share		$	(0.06	)		$	(0.50	)

The following table sets forth the computation of basic and diluted loss per share:

		Year ended December 31, 2024				Year ended December 31, 2023				Year ended December 31, 2022
Numerator:
Net loss attributable to Aptorum Group Limited		$	(4,267,806	)		$	(2,824,647	)		$	(9,799,560	)
Denominator:
Weighted average shares outstanding(1)
– Basic(1)			5,453,103				4,521,133				3,569,484
– Diluted(1)			5,453,103				4,521,133				3,569,484

Net loss per share attributable to Aptorum Group Limited(1)
– Basic(1)		$	(0.78	)		$	(0.62	)		$	(2.75	)
– Diluted(1)		$	(0.78	)		$	(0.62	)		$	(2.75	)

(1) All per share amounts and shares outstanding for all periods have been retroactively restated to reflect APTORUM GROUP LIMITED’s 1 for 10 reverse stock split, which was effective on January 23, 2023.

DiamiR Biosciences Corp. [Member]

Net Loss Per Share (Tables) [Line Items]

Schedule of Antidilutive Common Stock Equivalents

The following common stock equivalents have been excluded from the calculation of loss per share because their effects would be antidilutive:

		2025		2024
Stock options		511,950		511,950
Restricted stock		88,000		88,000
Warrants		—		29,336